DESIGN AND SYNTHESIS OF NEW EGFR- TYROSINE KINASE INHIBITORS CONTAINING PYRAZOLO[3,4-d]PYRIMIDINE CORES AS ANTICANCER AGENTS

Development of pyrazolo[1,5-a]pyrimidine derivatives: Synthesis, anticancer activity and docking study

Synthesis, Anticancer Activity and Molecular Docking Study of some New Thiazolo[2, 3-a]Pyrimidinedione-Based Heterocyclic Compounds

Design, Synthesis, QSAR, Molecular Docking Study and Antitumor Activity of some Novel Quinazolin-4(3H)-One Derivative

Novel Indene-[1,3,4]Oxadiazine hybrids: Design, construction, molecular docking, QSAR, ADME study and anticancer potential

Synthesis, Moleculer Docking and Anticancer Screening of Some Novel Tetrahydronaphthyl Thiazolyl Pyrazoles and other Related Derivatives

Design, synthesis and antiproliferative evaluation of novel pyrazolo-pyrimidine derivatives with expected cyclin-dependent kinase 2 inhibitory effect

Design, Sequential Synthesis, Kinase Inhibitors Comparative Docking, MD Simulations, 99mTc-Coupling and In-Vivo Studies of Novel Pyrazolopyrimidine Derivatives

Novel 2-oxo-tetrahydropyrimidine derivatives as BRAFV600E inhibitors targeting melanoma: Design, synthesis and anticancer activity

Novel Synthesis, Docking studies and Antitumor Evaluation of Pyrazolo- and Pyrazolo Aminophosphonate Derivatives Derived from N-Heterocyclic Amines